Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 2671 AL 2685

Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study

Kloberg A, Constantinescu R, Nilsson MK, Carlsson ML, Carlsson A, Wahlström J, Haghighi S.

Acta Neuropsychiatr. 2014 Oct;26(5):298-306. doi: 10.1017/neu.2014.16.

Molecular neurodegeneration: basic biology and disease pathways

Vassar R, Zheng H.

Mol Neurodegener. 2014 Sep 23;9:34. doi: 10.1186/1750-1326-9-34.

Mesenchymal stem cells: potential in treatment of neurodegenerative diseases

Tanna T, Sachan V.

Curr Stem Cell Res Ther. 2014;9(6):513-21. doi: 10.2174/1574888x09666140923101110.

Sigma receptors as potential therapeutic targets for neuroprotection

Nguyen L, Kaushal N, Robson MJ, Matsumoto RR.

Eur J Pharmacol. 2014 Nov 15;743:42-7. doi: 10.1016/j.ejphar.2014.09.022. Epub 2014 Sep 27.

Catatonia after cerebral hypoxia: do the usual treatments apply?

Quinn DK, Abbott CC.

Psychosomatics. 2014 Nov-Dec;55(6):525-35. doi: 10.1016/j.psym.2014.03.010. Epub 2014 Mar 27.

Chorea-ballism associated with ketotic hyperglycemia

Chen C, Zheng H, Yang L, Hu Z.

Neurol Sci. 2014 Dec;35(12):1851-5. doi: 10.1007/s10072-014-1968-1. Epub 2014 Sep 28.

Type 2 Transglutaminase, mitochondria and Huntington's disease: menage a trois

Altuntas S, D'Eletto M, Rossin F, Hidalgo LD, Farrace MG, Falasca L, Piredda L, Cocco S, Mastroberardino PG, Piacentini M, Campanella M.

Mitochondrion. 2014 Nov;19 Pt A:97-104. doi: 10.1016/j.mito.2014.09.008. Epub 2014 Sep 28.

Apathy and dementia. Nosology, assessment and management

Cipriani G, Lucetti C, Danti S, Nuti A.

J Nerv Ment Dis. 2014 Oct;202(10):718-24. doi: 10.1097/NMD.0000000000000190.

Clinical workout for the early detection of cognitive decline and dementia

Tsolaki M.

Eur J Clin Nutr. 2014 Nov;68(11):1186-91. doi: 10.1038/ejcn.2014.189. Epub 2014 Oct 1.

Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?

Scheuing L, Chiu CT, Liao HM, Linares GR, Chuang DM.

Int J Biol Sci. 2014 Sep 10;10(9):1024-38. doi: 10.7150/ijbs.9898. eCollection 2014.

The role of rab proteins in neuronal cells and in the trafficking of neurotrophin receptors

Bucci C, Alifano P, Cogli L.

Membranes (Basel). 2014 Oct 6;4(4):642-77. doi: 10.3390/membranes4040642.

Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review

Carlozzi NE, Miciura A, Migliore N, Dayalu P.

J Huntingtons Dis. 2014;3(3):233-52. doi: 10.3233/JHD-140115.

Improved Executive Function and Callosal White Matter Microstructure after Rhythm Exercise in Huntington's Disease

Metzler-Baddeley C, Cantera J, Coulthard E, Rosser A, Jones DK, Baddeley RJ.

J Huntingtons Dis. 2014;3(3):273-83. doi: 10.3233/JHD-140113.

Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease

Francelle L, Galvan L, Brouillet E.

Front Cell Neurosci. 2014 Sep 26;8:295. doi: 10.3389/fncel.2014.00295. eCollection 2014.

Bilateral hemiballism-hemi-chorea presenting in a diabetes taiwanese woman

Lin CM, Liu CK.

Neurol Int. 2014 Aug 8;6(3):5519. doi: 10.4081/ni.2014.5519. eCollection 2014 Aug 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias